azathioprine has been researched along with Syndrome, VKH (Vogt Koyanagi Harada) in 18 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After prednisolone and methotrexate failed to have the desired effect, he was treated with azathioprine, which caused pancytopenia, and manifested as fever with positive blood culture for a coagulase-negative staphylococcus infection." | 8.12 | Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report. ( Barman, P; Bhattarai, S; Khatri, S; Manandhar, D; Pyakurel, S; Regmi, S; Singh, AK, 2022) |
| "BACKGROUND The aim of this study was to describe the case of a 27-year-old woman who developed Vogt-Koyanagi-Harada (VKH) disease in the 13th week of pregnancy, who was treated with high-dose oral corticosteroids and azathioprine due to its persistent course." | 7.91 | Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study. ( Aguilera Partida, JA; Ingolotti, M; Roig Melo-Granados, EA; Ruiz García, H; Schlaen, BA, 2019) |
| "A VKH disease patient, well controlled on azathioprine therapy, presented a uveitis relapse eleven days after the first vaccination for COVID-19." | 4.12 | Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination. ( Accorinti, M; Manni, P; Saturno, MC, 2022) |
| " After prednisolone and methotrexate failed to have the desired effect, he was treated with azathioprine, which caused pancytopenia, and manifested as fever with positive blood culture for a coagulase-negative staphylococcus infection." | 4.12 | Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report. ( Barman, P; Bhattarai, S; Khatri, S; Manandhar, D; Pyakurel, S; Regmi, S; Singh, AK, 2022) |
| "BACKGROUND The aim of this study was to describe the case of a 27-year-old woman who developed Vogt-Koyanagi-Harada (VKH) disease in the 13th week of pregnancy, who was treated with high-dose oral corticosteroids and azathioprine due to its persistent course." | 3.91 | Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study. ( Aguilera Partida, JA; Ingolotti, M; Roig Melo-Granados, EA; Ruiz García, H; Schlaen, BA, 2019) |
| "To investigate the effectiveness, visual outcome, and prognostic factors of Vogt-Koyanagi-Harada (VKH) disease treatment with a reduced dose of corticosteroids combined with immunosuppressive agents." | 1.48 | Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. ( Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q, 2018) |
| "At the time of recurrence, four patients were on maintenance dose (5-10 mg/day) of oral corticosteroid while the remaining three were off treatment." | 1.35 | Posterior segment recurrences in Vogt-Koyanagi-Harada disease. ( Gupta, A; Gupta, V; Sachdev, N; Singh, R, 2008) |
| "We report a Chinese man with VKH syndrome presenting with multiple cranial nerve palsy and bilateral pan-uveitis, who developed disseminated high-grade B cell lymphoma after 3-year treatment with azathioprine." | 1.33 | High-grade lymphoma after azathioprine treatment for Vogt-Kaganayi-Harada syndrome. ( Au, WY; Ho, SL; Hon, C; Ma, ES; Trendell-Smith, NJ, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 5 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Accorinti, M | 1 |
| Saturno, MC | 1 |
| Manni, P | 1 |
| Khatri, S | 2 |
| Regmi, S | 1 |
| Pyakurel, S | 1 |
| Bhattarai, S | 1 |
| Barman, P | 1 |
| Manandhar, D | 1 |
| Singh, AK | 1 |
| Bajgai, P | 1 |
| Sharma, A | 1 |
| Singh, R | 2 |
| Khochtali, S | 1 |
| Mahjoub, A | 1 |
| Dridi, T | 1 |
| Ksiaa, I | 1 |
| Abroug, N | 1 |
| Khairallah, M | 1 |
| Silpa-Archa, S | 1 |
| Ittharat, W | 1 |
| Chotcomwongse, P | 1 |
| Preble, JM | 1 |
| Foster, CS | 2 |
| Yang, P | 1 |
| Ye, Z | 1 |
| Du, L | 1 |
| Zhou, Q | 1 |
| Qi, J | 1 |
| Liang, L | 1 |
| Wu, L | 1 |
| Wang, C | 1 |
| Kijlstra, A | 1 |
| Ingolotti, M | 1 |
| Schlaen, BA | 1 |
| Roig Melo-Granados, EA | 1 |
| Ruiz García, H | 1 |
| Aguilera Partida, JA | 1 |
| Wand, K | 1 |
| Abraham, S | 1 |
| Loos, D | 1 |
| Stumpfe, S | 1 |
| Lohmann, C | 1 |
| Maier, M | 1 |
| Feucht, N | 1 |
| Cuchacovich, M | 2 |
| Solanes, F | 1 |
| Díaz, G | 2 |
| Cermenati, T | 1 |
| Avila, S | 1 |
| Verdaguer, J | 2 |
| Verdaguer, JI | 2 |
| Carpentier, C | 1 |
| Stopel, J | 1 |
| Rojas, B | 2 |
| Traipe, L | 1 |
| Gallardo, P | 1 |
| Sabugo, F | 1 |
| Zanoli, M | 1 |
| Merino, G | 2 |
| Villarroel, F | 2 |
| Sifuentes Giraldo, WA | 1 |
| de la Puente Bujidos, C | 1 |
| de Blas Beorlegui, G | 1 |
| López San Román, A | 1 |
| Peña Arrebola, A | 1 |
| Arcinue, CA | 1 |
| Radwan, A | 1 |
| Lebanan, MO | 1 |
| Kohnen, EM | 1 |
| Pansdorf, Y | 1 |
| Zubcov, A | 1 |
| Hon, C | 1 |
| Ho, SL | 1 |
| Ma, ES | 1 |
| Trendell-Smith, NJ | 1 |
| Au, WY | 1 |
| Agarwal, M | 1 |
| Ganesh, SK | 1 |
| Biswas, J | 1 |
| Pacheco, P | 1 |
| Stoppel, J | 1 |
| Sachdev, N | 1 |
| Gupta, V | 1 |
| Gupta, A | 1 |
| Menger, H | 1 |
| Neukäter, W | 1 |
| Kroll, S | 1 |
| Jörg, J | 1 |
| Sundmacher, R | 1 |
2 trials available for azathioprine and Syndrome, VKH (Vogt Koyanagi Harada)
| Article | Year |
|---|---|
Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Dose-Respon | 2010 |
[Role of Azathioprine in steroid resistant non infectious ocular inflammatory diseases].
Topics: Adolescent; Adult; Aged; Azathioprine; Choroid Diseases; Drug Resistance; Drug Therapy, Combination; | 2007 |
16 other studies available for azathioprine and Syndrome, VKH (Vogt Koyanagi Harada)
| Article | Year |
|---|---|
Vogt-Koyanagi-Harada Relapse after COVID-19 Vaccination.
Topics: Adrenal Cortex Hormones; Azathioprine; Chronic Disease; COVID-19; COVID-19 Vaccines; Female; Humans; | 2022 |
Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancytopenia; Prednisolone; Uveom | 2022 |
Disseminated Tubercular Granulomas Associated with the Use of Azathioprine.
Topics: Antitubercular Agents; Azathioprine; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiogra | 2021 |
Cytomegalovirus retinitis following corticosteroid overdose for Vogt-Koyanagi-Harada disease.
Topics: Adult; Azathioprine; Cytomegalovirus Retinitis; Female; Humans; Immunosuppressive Agents; Uveomening | 2020 |
Analysis of Three-Dimensional Choroidal Volume with Enhanced Depth Imaging Findings in Patients with Recurrent Vogt-Koyanagi-Harada Disease.
Topics: Adult; Aged; Azathioprine; Choroid; Cyclosporine; Female; Fluorescein Angiography; Humans; Imaging, | 2021 |
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein | 2018 |
Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study.
Topics: Adult; Angiography; Azathioprine; Female; Humans; Immunosuppressive Agents; Multimodal Imaging; Preg | 2019 |
[Long-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Drug Substitution; Female; Follow-Up Stu | 2015 |
Herpes zoster motor neuropathy in a patient with previous motor paresis secondary to Vogt-Koyanagi-Harada disease.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Disease Progression; Electromyography; Female; Herpes Zost | 2013 |
Comparison of two different combination immunosuppressive therapies in the treatment of Vogt-Koyonagi-Harada syndrome.
Topics: Adult; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fema | 2013 |
[Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome].
Topics: Azathioprine; Child; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combin | 2004 |
High-grade lymphoma after azathioprine treatment for Vogt-Kaganayi-Harada syndrome.
Topics: Adult; Azathioprine; Carcinogens; Cranial Nerve Diseases; Humans; Immunophenotyping; Lymph Nodes; Ly | 2005 |
Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Fundus Ocul | 2006 |
Posterior segment recurrences in Vogt-Koyanagi-Harada disease.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Hu | 2008 |
[The Vogt-Koyanagi-Harada uveomeningoencephalitic syndrome].
Topics: Adult; Autoimmune Diseases; Azathioprine; Cortisone; Diagnosis, Differential; Dose-Response Relation | 1994 |
[Diagnosis of Vogt-Koyanagi-Harada-syndrome (uveoencephalitis) (author's transl)].
Topics: Adult; Azathioprine; Diagnosis, Differential; Female; Fundus Oculi; Germany, West; Glucocorticoids; | 1975 |